Christopher Peetz
2020
In 2020, Christopher Peetz earned a total compensation of $3M as Chief Executive Officer and President at Mirum Pharmaceuticals, a 52% decrease compared to previous year.
Compensation breakdown
| Bonus | $265,952 |
|---|---|
| Option Awards | $2,218,755 |
| Salary | $511,818 |
| Other | $7,453 |
| Total | $3,003,978 |
Peetz received $2.2M in option awards, accounting for 74% of the total pay in 2020.
Peetz also received $266K in bonus, $511.8K in salary and $7.5K in other compensation.
Rankings
In 2020, Christopher Peetz's compensation ranked 3,840th out of 13,090 executives tracked by ExecPay. In other words, Peetz earned more than 70.7% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 3,840 out of 13,090 | 71st |
Division Manufacturing | 1,529 out of 5,621 | 73rd |
Major group Chemicals And Allied Products | 579 out of 2,254 | 74th |
Industry group Drugs | 498 out of 1,954 | 75th |
Industry Pharmaceutical Preparations | 376 out of 1,459 | 74th |
Source: SEC filing on April 14, 2021.
Peetz's colleagues
We found two more compensation records of executives who worked with Christopher Peetz at Mirum Pharmaceuticals in 2020.
News
Mirum Pharmaceuticals CEO Christopher Peetz's 2023 pay jumps 47% to $6.5M
April 23, 2024
Mirum Pharmaceuticals CEO Christopher Peetz's 2022 pay rises 7% to $4.4M
May 1, 2023
Mirum Pharmaceuticals CEO Christopher Peetz's 2021 pay jumps 38% to $4.1M
April 22, 2022
Mirum Pharmaceuticals CEO Christopher Peetz's 2020 pay falls 52% to $3M
April 14, 2021